FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002106501> ?p ?o ?g. }

• W2002106501 endingPage "e75377" @default.
• W2002106501 startingPage "e75377" @default.
• W2002106501 abstract "The development of new boron-delivery agents is a high priority for improving the effectiveness of boron neutron capture therapy. In the present study, 1-amino-3-borono-cyclopentanecarboxylic acid (cis-ABCPC) as a mixture of its L- and D-enantiomers was evaluated in vivo using the B16 melanoma model for the human tumor and the F98 rat glioma as a model for human gliomas. A secondary ion mass spectrometry (SIMS) based imaging instrument, CAMECA IMS 3F SIMS Ion Microscope, was used for quantitative imaging of boron at 500 nm spatial resolution. Both in vivo and in vitro studies in melanoma models demonstrated that boron was localized in the cytoplasm and nuclei with some cell-to-cell variability. Uptake of cis-ABCPC in B16 cells was time dependent with a 7.5:1 partitioning ratio of boron between cell nuclei and the nutrient medium after 4 hrs. incubation. Furthermore, cis-ABCPC delivered boron to cells in all phases of the cell cycle, including S-phase. In vivo SIMS studies using the F98 rat glioma model revealed an 8:1 boron partitioning ratio between the main tumor mass and normal brain tissue with a 5:1 ratio between infiltrating tumor cells and contiguous normal brain. Since cis-ABCPC is water soluble and can cross the blood-brain-barrier via the L-type amino acid transporters (LAT), it may accumulate preferentially in infiltrating tumor cells in normal brain due to up-regulation of LAT in high grade gliomas. Once trapped inside the tumor cell, cis-ABCPC cannot be metabolized and remains either in a free pool or bound to cell matrix components. The significant improvement in boron uptake by both the main tumor mass and infiltrating tumor cells compared to those reported in animal and clinical studies of p-boronophenylalanine strongly suggest that cis-ABCPC has the potential to become a novel new boron delivery agent for neutron capture therapy of gliomas and melanomas." @default.
• W2002106501 created "2016-06-24" @default.
• W2002106501 creator A5002185510 @default.
• W2002106501 creator A5012238012 @default.
• W2002106501 creator A5023164401 @default.
• W2002106501 creator A5038404075 @default.
• W2002106501 creator A5052903538 @default.
• W2002106501 creator A5055649265 @default.
• W2002106501 creator A5082481721 @default.
• W2002106501 date "2013-09-18" @default.
• W2002106501 modified "2023-10-09" @default.
• W2002106501 title "Biodistribution and Subcellular Localization of an Unnatural Boron-Containing Amino Acid (Cis-ABCPC) by Imaging Secondary Ion Mass Spectrometry for Neutron Capture Therapy of Melanomas and Gliomas" @default.
• W2002106501 cites W145650598 @default.
• W2002106501 cites W1563433962 @default.
• W2002106501 cites W1964358584 @default.
• W2002106501 cites W1983609602 @default.
• W2002106501 cites W1985156459 @default.
• W2002106501 cites W1991142673 @default.
• W2002106501 cites W1991788723 @default.
• W2002106501 cites W2003048144 @default.
• W2002106501 cites W2012493188 @default.
• W2002106501 cites W2032133671 @default.
• W2002106501 cites W2032925210 @default.
• W2002106501 cites W2034148500 @default.
• W2002106501 cites W2036964732 @default.
• W2002106501 cites W2039364424 @default.
• W2002106501 cites W2042492547 @default.
• W2002106501 cites W2050546601 @default.
• W2002106501 cites W2050841253 @default.
• W2002106501 cites W2054232940 @default.
• W2002106501 cites W2055309966 @default.
• W2002106501 cites W2068572063 @default.
• W2002106501 cites W2089009444 @default.
• W2002106501 cites W2095655314 @default.
• W2002106501 cites W2099258829 @default.
• W2002106501 cites W2122839902 @default.
• W2002106501 cites W2124671697 @default.
• W2002106501 cites W2134331076 @default.
• W2002106501 cites W2145030327 @default.
• W2002106501 cites W2147522400 @default.
• W2002106501 cites W2150371702 @default.
• W2002106501 cites W2150441363 @default.
• W2002106501 cites W2413084314 @default.
• W2002106501 cites W2485005830 @default.
• W2002106501 cites W2951438911 @default.
• W2002106501 cites W3209818038 @default.
• W2002106501 cites W4229550919 @default.
• W2002106501 cites W4244591174 @default.
• W2002106501 doi "https://doi.org/10.1371/journal.pone.0075377" @default.
• W2002106501 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3776788" @default.
• W2002106501 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24058680" @default.
• W2002106501 hasPublicationYear "2013" @default.
• W2002106501 type Work @default.
• W2002106501 sameAs 2002106501 @default.
• W2002106501 citedByCount "22" @default.
• W2002106501 countsByYear W20021065012014 @default.
• W2002106501 countsByYear W20021065012015 @default.
• W2002106501 countsByYear W20021065012016 @default.
• W2002106501 countsByYear W20021065012017 @default.
• W2002106501 countsByYear W20021065012018 @default.
• W2002106501 countsByYear W20021065012019 @default.
• W2002106501 countsByYear W20021065012020 @default.
• W2002106501 countsByYear W20021065012022 @default.
• W2002106501 crossrefType "journal-article" @default.
• W2002106501 hasAuthorship W2002106501A5002185510 @default.
• W2002106501 hasAuthorship W2002106501A5012238012 @default.
• W2002106501 hasAuthorship W2002106501A5023164401 @default.
• W2002106501 hasAuthorship W2002106501A5038404075 @default.
• W2002106501 hasAuthorship W2002106501A5052903538 @default.
• W2002106501 hasAuthorship W2002106501A5055649265 @default.
• W2002106501 hasAuthorship W2002106501A5082481721 @default.
• W2002106501 hasBestOaLocation W20021065011 @default.
• W2002106501 hasConcept C12554922 @default.
• W2002106501 hasConcept C1491633281 @default.
• W2002106501 hasConcept C150903083 @default.
• W2002106501 hasConcept C162356407 @default.
• W2002106501 hasConcept C178790620 @default.
• W2002106501 hasConcept C185592680 @default.
• W2002106501 hasConcept C202751555 @default.
• W2002106501 hasConcept C207001950 @default.
• W2002106501 hasConcept C24066741 @default.
• W2002106501 hasConcept C2777807558 @default.
• W2002106501 hasConcept C2778227246 @default.
• W2002106501 hasConcept C43617362 @default.
• W2002106501 hasConcept C501308230 @default.
• W2002106501 hasConcept C502942594 @default.
• W2002106501 hasConcept C55493867 @default.
• W2002106501 hasConcept C77671233 @default.
• W2002106501 hasConcept C86803240 @default.
• W2002106501 hasConceptScore W2002106501C12554922 @default.
• W2002106501 hasConceptScore W2002106501C1491633281 @default.
• W2002106501 hasConceptScore W2002106501C150903083 @default.
• W2002106501 hasConceptScore W2002106501C162356407 @default.
• W2002106501 hasConceptScore W2002106501C178790620 @default.
• W2002106501 hasConceptScore W2002106501C185592680 @default.
• W2002106501 hasConceptScore W2002106501C202751555 @default.
• W2002106501 hasConceptScore W2002106501C207001950 @default.
• W2002106501 hasConceptScore W2002106501C24066741 @default.

• next